Bolt Biotherapeutics Inc (BOLT)
0.63
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 16:00
0.63
0.00 (0.00%)
After-Hours: 17:39
Bolt Biotherapeutics Free Cash Flow (Quarterly): -16.14M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -16.14M |
March 31, 2024 | -16.75M |
December 31, 2023 | -14.27M |
September 30, 2023 | -16.91M |
June 30, 2023 | -15.14M |
March 31, 2023 | -23.40M |
December 31, 2022 | -18.14M |
September 30, 2022 | -14.19M |
June 30, 2022 | -21.22M |
Date | Value |
---|---|
March 31, 2022 | -24.92M |
December 31, 2021 | -18.36M |
September 30, 2021 | -19.74M |
June 30, 2021 | -4.689M |
March 31, 2021 | -16.62M |
December 31, 2020 | -13.79M |
September 30, 2020 | -13.67M |
June 30, 2020 | -13.10M |
March 31, 2020 | -10.01M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-24.92M
Minimum
Mar 2022
-4.689M
Maximum
Jun 2021
-16.17M
Average
-16.38M
Median
Free Cash Flow (Quarterly) Benchmarks
SeaStar Medical Holding Corp | -2.824M |
NovaBay Pharmaceuticals Inc | -0.58M |
Palatin Technologies Inc | -6.477M |
iBio Inc | -4.854M |
Theriva Biologics Inc | -3.453M |